These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27755238)

  • 1. Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
    Madeddu C; Deidda M; Piras A; Cadeddu C; Demurtas L; Puzzoni M; Piscopo G; Scartozzi M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e12-e18. PubMed ID: 27755238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
    Madeddu C; Deidda M; Piras A; Cadeddu C; Demurtas L; Puzzoni M; Piscopo G; Scartozzi M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S12-8. PubMed ID: 27183520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of anthracycline cardiotoxicity.
    Mele D; Tocchetti CG; Pagliaro P; Madonna R; Novo G; Pepe A; Zito C; Maurea N; Spallarossa P
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e3-e11. PubMed ID: 27755237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
    Pai VB; Nahata MC
    Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
    Feola M; Garrone O; Occelli M; Francini A; Biggi A; Visconti G; Albrile F; Bobbio M; Merlano M
    Int J Cardiol; 2011 Apr; 148(2):194-8. PubMed ID: 19945181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular toxicities of cancer chemotherapy.
    Bonita R; Pradhan R
    Semin Oncol; 2013 Apr; 40(2):156-67. PubMed ID: 23540741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of anthracycline cardiotoxicity.
    Mele D; Tocchetti CG; Pagliaro P; Madonna R; Novo G; Pepe A; Zito C; Maurea N; Spallarossa P
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S3-S11. PubMed ID: 27183523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
    O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmia and Electrophysiological Effects of Chemotherapy: A Review.
    Markman TM; Nazarian S
    Oncology; 2016; 91(2):61-8. PubMed ID: 27256307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of cytotoxic drugs.
    Schimmel KJ; Richel DJ; van den Brink RB; Guchelaar HJ
    Cancer Treat Rev; 2004 Apr; 30(2):181-91. PubMed ID: 15023436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on cardiotoxicity of anti-cancer treatments.
    Rosa GM; Gigli L; Tagliasacchi MI; Di Iorio C; Carbone F; Nencioni A; Montecucco F; Brunelli C
    Eur J Clin Invest; 2016 Mar; 46(3):264-84. PubMed ID: 26728634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-induced chronic cardiotoxicity and heart failure.
    Appel JM; Nielsen D; Zerahn B; Jensen BV; Skagen K
    Acta Oncol; 2007; 46(5):576-80. PubMed ID: 17562433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer.
    Mihalcea DJ; Florescu M; Vinereanu D
    Am J Ther; 2017; 24(1):e3-e11. PubMed ID: 27145188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of systemic agents used in breast cancer.
    Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
    Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline cardiotoxicity.
    Menna P; Paz OG; Chello M; Covino E; Salvatorelli E; Minotti G
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S21-36. PubMed ID: 21635149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of chemotherapies].
    Castel M; Despas F; Modesto A; Gales C; Honton B; Galinier M; Senard JM; Pathak A
    Presse Med; 2013 Jan; 42(1):26-39. PubMed ID: 22727981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
    Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e19-e26. PubMed ID: 27755239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention.
    Cadeddu Dessalvi C; Deidda M; Mele D; Bassareo PP; Esposito R; Santoro C; Lembo M; Galderisi M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.